Compare
Regencell Bioscience Holdings Ltd vs Cyanotech Corp vs Mannatech Inc vs Leef Brands Inc.
| Latest fiscal year | Regencell Bioscience Holdings Ltd RGC | Cyanotech Corp CYAN | Mannatech Inc MTEX | Leef Brands Inc. LEEEF |
|---|---|---|---|---|
| Year ended | 2025-06-30 | 2025-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $24.21M | $108.04M | $34.79M |
| Revenue growth (YoY) | n/a | +5.0% | -8.3% | +22.1% |
| Gross margin | n/a | 28.4% | 74.9% | 30.1% |
| Operating margin | n/a | -10.4% | -0.4% | -21.8% |
| Net margin | n/a | -13.2% | -14.1% | -50.7% |
| Net income | -$3.58M | -$3.20M | -$15.21M | -$17.63M |
| EPS (Diluted) | -$0.72 | n/a | -$8.00 | -$0.10 |
| Operating cash flow | -$3.11M | -$1.19M | -$2.96M | -$336.9K |
| Free cash flow | -$3.27M | n/a | -$4.32M | -$978.9K |
| Cash & equivalents | n/a | $257.0K | $6.18M | $2.19M |
| Total assets | $5.76M | $23.49M | $29.99M | $36.40M |
| Total liabilities | $895.3K | $14.61M | $35.22M | $44.67M |
| Shareholders' equity | $4.86M | $8.88M | -$5.22M | -$8.27M |
| Return on year-end equity | -73.7% | -36.1% | n/a | n/a |
| Shares outstanding | 494.49M | 7.20M | 1.90M | 257.95M |
Revenue, most recent five fiscal years
| Fiscal year | Regencell Bioscience Holdings Ltd | Cyanotech Corp | Mannatech Inc | Leef Brands Inc. |
|---|---|---|---|---|
| Latest | n/a | $24.21M Ended 2025-03-31 | $108.04M Ended 2025-12-31 | $34.79M Ended 2025-12-31 |
| 1 year earlier | n/a | $23.07M Ended 2024-03-31 | $117.87M Ended 2024-12-31 | $28.50M Ended 2024-12-31 |
| 2 years earlier | n/a | $23.18M Ended 2023-03-31 | $131.96M Ended 2023-12-31 | n/a |
| 3 years earlier | n/a | $35.97M Ended 2022-03-31 | $137.21M Ended 2022-12-31 | n/a |
| 4 years earlier | n/a | $32.34M Ended 2021-03-31 | $159.76M Ended 2021-12-31 | n/a |